trending Market Intelligence /marketintelligence/en/news-insights/trending/-aDvpzK50ceMDk4DMjDeGg2 content esgSubNav
In This List

Odonate Therapeutics appoints director

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


Odonate Therapeutics appoints director

Odonate Therapeutics Inc. appointed Laura Douglass to its board, effective Dec. 3.

Douglass is the president and CEO of Next Generation Clinical Research Consulting Inc., a contract research organization in the pharmaceutical industry.

Odonate Therapeutics is a pharmaceutical company developing treatments for cancer.